Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
VALIANTLAB
VALIANTLAB

Valiant Laboratories Ltd.

NSE: VALIANTLAB
BSE: 543998
Sector: Healthcare
Industry: Pharmaceuticals
128.43-2.6 (-2.00%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

8.5 / 100

Value Score

20.4 / 100

Price Momentum Score

97.9 / 100

QVM Score

30.7 / 100

Key Metrics

Market Cap
697.54
P/E (TTM)
43.58
P/B
2.24
P/S (TTM)
2.28
EV/EBITDA
21.36
CAPE (5Y)
31.59
ROE (TTM)
-1.20
ROCE (TTM)
0.10
ROA (TTM)
-0.76
Avg 3Y ROE
-0.65
Earnings 3Y CAGR
-27.27
Sales 3Y CAGR
-10.74
Sales 5Y CAGR
-
Debt/Equity
0.15
Consensus TP
-
Strong Buy %
-
Promoter Holding
74.94
Pledged %
0.00

Share Price

Track Valiant Laboratories Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -4.62 %
Low
128.4
High
141.4
1 Month returns: 4.42 %
Low
113.0
High
141.4
1 Year returns: 50.55 %
Low
49.5
High
141.4
3 Year CAGR: -8.32 %
Low
49.5
High
199.6
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Valiant Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Valiant Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Valiant Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Valiant Laboratories Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Valiant Laboratories Ltd.?
The current share price of Valiant Laboratories Ltd. is ₹ 128.43 as of 23 Oct 2026.
What is the market capitalisation of Valiant Laboratories Ltd.?
The market capitalisation of Valiant Laboratories Ltd. stands at ₹ 697.54 Cr.
What is the PE ratio of Valiant Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Valiant Laboratories Ltd. is 43.58 as of the latest trailing twelve months data.
What is the ROE and ROCE of Valiant Laboratories Ltd.?
Valiant Laboratories Ltd. has a Return on Equity (ROE) of -1.20% and a Return on Capital Employed (ROCE) of 0.10% as per the latest financial reports.
What is the 52-week high and low of Valiant Laboratories Ltd.?
The 52-week high of Valiant Laboratories Ltd. is - and the 52-week low is -.
What is the dividend yield of Valiant Laboratories Ltd.?
The dividend yield of Valiant Laboratories Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Valiant Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 0.07%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 21.73% of Valiant Laboratories Ltd. shares.
What sector does Valiant Laboratories Ltd. belong to?
Valiant Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Valiant Laboratories Ltd.?
The beta of Valiant Laboratories Ltd. is 0.99, indicating its price volatility relative to the broader market. Over the past 1 year, Valiant Laboratories Ltd. has delivered an absolute return of 54.21%.
What is the RSI of Valiant Laboratories Ltd.?
The 14-day Relative Strength Index (RSI) of Valiant Laboratories Ltd. is 55.73, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.